Allakos Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALLK research report →
About the company
Allakos Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic agents. These treatments are designed to target specific immunomodulatory receptors on immune effector cells, addressing a spectrum of allergic, inflammatory, and proliferative conditions.
- CEO
- Robert Alexander
- IPO
- 2018
- Employees
- 131
- HQ
- San Carlos, CA, US
Price Chart
- Market Cap
- $29.74M
- P/E
- -0.25
- P/S
- 0.00
- P/B
- 0.37
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -93.54%
- ROIC
- -140.27%
- Revenue
- $0 · 0.00%
- Net Income
- $-115,818,000 · 37.63%
- EPS
- $-1.30 · 39.25%
- Op Income
- $-122,225,000
- FCF YoY
- 19.93%
- 52W High
- $1.56
- 52W Low
- $0.22
- 50D MA
- $0.27
- 200D MA
- $0.74
- Beta
- 0.14
- Avg Volume
- 2.85M
Get TickerSpark's AI analysis on ALLK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 25 | BVF PARTNERS L P/IL | sell | 855,211 |
| May 15, 25 | Walker Paul Edward | sell | 3,386,400 |
| May 15, 25 | Walker Paul Edward | sell | 37,600 |
| May 15, 25 | Walker Paul Edward | sell | 16,000 |
| May 15, 25 | Walker Paul Edward | sell | 7,700 |
| May 15, 25 | Walker Paul Edward | sell | 7,700 |
| May 15, 25 | Walker Paul Edward | sell | 99,590 |
| May 15, 25 | Walker Paul Edward | sell | 86,762 |
| May 15, 25 | Walker Paul Edward | sell | 41,000 |
| May 15, 25 | Tomasi Adam | sell | 1,200,000 |
Our ALLK coverage
Recent articles, reports, and earnings notes.
No research on ALLK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALLK report →Similar companies
Peers in the same neighborhood.